Keywords: ceptor, deal, buy, ferring, r-h, cuznsod, usa-based
CepTor in deal to buy Ferring's r-h CuZnSOD
Article | 25 September 2006
USA-based biopharmaceutical company CepTor, a specialist in the field of neuromuscular and neurodegenerative diseases, says it has signed a letter ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
